Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novozymes A/S    NZYM B   DK0060336014

NOVOZYMES A/S

(NZYM B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Novozymes A/S : Trading by management and close relations of management

10/22/2020 | 08:23am EST

Please read the full announcement in PDF


Attachment

  • 2020_59_Trading_by_management_EN

© OMX, source OMX

All news about NOVOZYMES A/S
01/08NOVOZYMES A/S : completes acquisition of Microbiome Labs
AQ
01/05NOVOZYMES A/S : New enzyme makes high protein drinks taste better
PU
2020NOVOZYMES A/S : acquires Microbiome Labs and adds a strong position in the North..
PU
2020NOVOZYMES A/S : acquires Microbiome Labs
AQ
2020NOVOZYMES A/S : switches to renewable electricity in North America
PU
2020NOVOZYMES A/S : New sales reporting structure introduced. 2020 organic sales gro..
AQ
2020NOVOZYMES A/S : New bioenergy enzyme solution harnesses the untapped potential o..
PU
2020NOVOZYMES A/S : New biological solution strengthens gluten and improves dough
PU
2020NOVOZYMES A/S : Proposal of candidates to the Board of Directors
AQ
2020NOVOZYMES A/S : Change of management
AQ
More news
Financials
Sales 2020 14 105 M 2 296 M 2 296 M
Net income 2020 2 868 M 467 M 467 M
Net Debt 2020 4 302 M 700 M 700 M
P/E ratio 2020 36,7x
Yield 2020 1,46%
Capitalization 105 B 17 180 M 17 106 M
EV / Sales 2020 7,76x
EV / Sales 2021 7,55x
Nbr of Employees 6 180
Free-Float 71,9%
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 19
Average target price 354,94 DKK
Last Close Price 375,00 DKK
Spread / Highest target 22,7%
Spread / Average Target -5,35%
Spread / Lowest Target -24,5%
EPS Revisions
Managers and Directors
NameTitle
Ester Baiget President & Chief Executive Officer
Jørgen Buhl Rasmussen Chairman
Graziela Chaluppe dos Santos Malucelli Chief Operating Officer & Executive VP
Lars Green Chief Financial Officer & Executive Vice President
Claus Crone Fuglsang Chief Scientific Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
NOVOZYMES A/S7.30%17 180
ECOLAB INC.-3.25%59 752
SIKA AG2.44%39 562
GIVAUDAN SA-0.08%38 759
EMS-CHEMIE HOLDING AG-1.47%22 152
SYMRISE AG-4.57%17 040